CoChat

Survival Benefit of the Primary Prevention Implantable Cardioverter-Defibrillator Among Older Patients: Does Age Matter? An Analysis of Pooled Data From 5 Clinical Trials

Open access
Hess, Paul L., Al-Khatib, Sana M., Han, Joo Y., Edwards, Rex, Bardy, Gust H., Bigger, J. Thomas, Buxton, Alfred, Cappato, Riccardo, Dorian, Paul, Hallstrom, Al, Kadish, Alan H., Kudenchuk, Peter J., Lee, Kerry L., Mark, Daniel B., Moss, Arthur J., Steinman, Richard, Inoue, Lurdes Y.T., Sanders, Gillian · 2015 · Circulation: Cardiovascular Quality and Outcomes
Cited by 107

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background—: The impact of patient age on the risks of death or rehospitalization after primary prevention implantable cardioverter-defibrillator (ICD) placement is uncertain. Methods and Results—: Data from 5 major ICD trials were merged: the Multicenter Automatic Defibrillator Implantation Trial I (MADIT-I), the Multicenter UnSustained Tachycardia Trial (MUSTT), the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II), the Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation Trial (DEFINITE), and the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Median age at enrollment was 62 (interquartile range 53–70) years. Compared with their younger counterparts, older patients had a greater burden of comorbid illness. In unadjusted exploratory analyses, ICD recipients were less likely to die than nonrecipients in all age groups: among patients aged <55 years: hazard ratio 0.48, 95% posterior credible interval 0.33 to 0.69; among patients aged 55 to 64 years: hazard ratio 0.69, 95% posterior credible interval 0.53 to 0.90; among patients aged 65 to 74 years: hazard ratio 0.67, 95% posterior credible interval, 0.53 to 0.85; and among patients aged ≥75 years: hazard ratio 0.54, 95% posterior credible interval 0.37 to 0.78. Sample sizes were limited among patients aged ≥75 years. In adjusted Bayesian–Weibull modeling, point estimates indicate ICD efficacy persists but is attenuated with increasing age. There was evidence of an interaction between age and ICD treatment on survival (two-sided posterior tail probability of no interaction <0.01). Using an adjusted Bayesian logistic regression model, there was no evidence of an interaction between age and ICD treatment on rehospitalization (two-sided posterior tail probability of no interaction 0.44). Conclusions—: In this analysis, the survival benefit of the ICD exists but is attenuated with increasing age. The latter finding may be because of the higher burden of comorbid illness, competing causes of death, or limited sample size of older patients. There was no evidence that age modifies the association between ICD treatment and rehospitalization.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circoutcomes.114.001306

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 107

Metadata

Authors
Hess, P. L., Al-Khatib, S. M., Han, J. Y., Edwards, R., Bardy, G. H., Bigger, J. T., Buxton, A., Cappato, R., Dorian, P., Hallstrom, A., Kadish, A. H., Kudenchuk, P. J., Lee, K. L., Mark, D. B., Moss, A. J., Steinman, R., Inoue, L. Y. T., & Sanders, G.
Venue
Circulation: Cardiovascular Quality and Outcomes
Published
2015-03
Volume
8
Issue
2
Pages
179-186
ISSN
  • 1941-7705 (ISSN-L)
  • 1941-7713
OpenAlex
W2120179950
Cited by
107
References
5
FWCI
12.05
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Survival Benefit of the Primary Prevention Implantable Cardioverter-Defibrillator Among Older Patients: Does Age Matter? An Analysis of Pooled Data From 5 Clinical Trials. https://app.cochat.ai/papers/10.1161/circoutcomes.114.001306
The paper
Hess, P. L., Al-Khatib, S. M., Han, J. Y., Edwards, R., Bardy, G. H., Bigger, J. T., Buxton, A., Cappato, R., Dorian, P., Hallstrom, A., Kadish, A. H., Kudenchuk, P. J., Lee, K. L., Mark, D. B., Moss, A. J., Steinman, R., Inoue, L. Y. T., & Sanders, G. (2015). Survival Benefit of the Primary Prevention Implantable Cardioverter-Defibrillator Among Older Patients: Does Age Matter? An Analysis of Pooled Data From 5 Clinical Trials. Circulation: Cardiovascular Quality and Outcomes. https://doi.org/10.1161/circoutcomes.114.001306

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.